Manager × security

PERCEPTIVE ADVISORS LLC APGE holdings history

Who else holds this security? →

APOGEE THERAPEUTICS INC · CUSIP 03770N101 · CIK 1224962

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Log in to see them.
Citable facts

As of Jun 30, 2026, PERCEPTIVE ADVISORS LLC reported 1.31M APGE (shares), valued at $173.63M, or 2.70% of its reported non-derivative portfolio. Filed Aug 14, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
2.70%
Shares
1.31M
1,308,113
Reported value
$173.63M
USD

Shares decreased 15.08%; reported value increased 33.91%, and weight changed +0.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q3 2026Not reportedNot reported—
Q2 20262.70%1,308,113SEC filing ↗Filed Aug 14, 2026
Q1 20262.56%1,540,384SEC filing ↗Filed May 29, 2026Amended
Q4 20253.22%2,330,651SEC filing ↗Filed Feb 17, 2026
Q3 20251.55%1,351,989SEC filing ↗Filed Nov 14, 2025
Q2 20251.93%1,182,148SEC filing ↗Filed Aug 14, 2025
Q1 20251.49%1,122,767SEC filing ↗Filed Aug 6, 2025Amended
Q4 20241.32%1,047,232SEC filing ↗Filed Feb 14, 2025
Q3 20242.54%2,015,007SEC filing ↗Filed Nov 14, 2024
Q2 20242.00%2,105,636SEC filing ↗Filed Aug 16, 2024Amended
Q1 20242.41%2,060,395SEC filing ↗Filed Aug 6, 2024Amended
Q4 20231.14%1,827,901SEC filing ↗Filed Feb 26, 2024Amended

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20231.14%1,827,901$51.07MThe prior quarter is outside the free window. Log in for the comparison.SEC filing ↗
Filed Feb 26, 2024
Q1 20242.41%2,060,395$136.91MShares increased 12.72%; reported value increased 168.08%, and weight changed +1.27 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 6, 2024
Q2 20242.00%2,105,636$82.86MShares increased 2.20%; reported value decreased 39.48%, and weight changed -0.41 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 16, 2024
Q3 20242.54%2,015,007$118.36MShares decreased 4.30%; reported value increased 42.85%, and weight changed +0.54 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20241.32%1,047,232$47.44MShares decreased 48.03%; reported value decreased 59.92%, and weight changed -1.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20251.49%1,122,767$41.95MShares increased 7.21%; reported value decreased 11.58%, and weight changed +0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 6, 2025
Q2 20251.93%1,182,148$51.34MShares increased 5.29%; reported value increased 22.40%, and weight changed +0.44 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20251.55%1,351,989$53.71MShares increased 14.37%; reported value increased 4.62%, and weight changed -0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20253.22%2,330,651$175.92MShares increased 72.39%; reported value increased 227.50%, and weight changed +1.67 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20262.56%1,540,384$129.65MShares decreased 33.91%; reported value decreased 26.30%, and weight changed -0.66 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 29, 2026
Q2 20262.70%1,308,113$173.63MShares decreased 15.08%; reported value increased 33.91%, and weight changed +0.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Q3 2026Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
PERCEPTIVE ADVISORS LLC · APOGEE THERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_institutional_holdings
{"action":"portfolio","cik":"1224962","quarter":"2026Q2","cusip":"03770N101"}

akkru_institutional_holdings
{"action":"history","cik":"1224962","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP / CLI documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.